| Outgoing Relation(s) |
| tertiary amino compound (CHEBI:50996) is a organic amino compound (CHEBI:50047) |
| tertiary amino compound (CHEBI:50996) is conjugate base of tertiary ammonium ion (CHEBI:137982) |
| Incoming Relation(s) |
| tertiary amine oxide (CHEBI:134363) has functional parent tertiary amino compound (CHEBI:50996) |
| (+)-butaclamol (CHEBI:73298) is a tertiary amino compound (CHEBI:50996) |
| (+)-minovincinine (CHEBI:145195) is a tertiary amino compound (CHEBI:50996) |
| (R)-8-[(dimethylamino)methyl]-1-[3-(dimethylamino)propyl]-1,7,8,9-tetrahydrochromeno[5,6-d]imidazol-2-amine (CHEBI:72332) is a tertiary amino compound (CHEBI:50996) |
| (R)-laudanosine (CHEBI:136734) is a tertiary amino compound (CHEBI:50996) |
| (S)-codamine (CHEBI:145336) is a tertiary amino compound (CHEBI:50996) |
| (S)-corytuberine (CHEBI:81200) is a tertiary amino compound (CHEBI:50996) |
| (S)-glaucine (CHEBI:5373) is a tertiary amino compound (CHEBI:50996) |
| (S)-nandinine (CHEBI:132749) is a tertiary amino compound (CHEBI:50996) |
| (−)-echitovenine (CHEBI:4752) is a tertiary amino compound (CHEBI:50996) |
| (−)-minovincinine (CHEBI:6941) is a tertiary amino compound (CHEBI:50996) |
| (−)-noscapine (CHEBI:73237) is a tertiary amino compound (CHEBI:50996) |
| (−)-noscapine hemiacetal (CHEBI:141667) is a tertiary amino compound (CHEBI:50996) |
| (−)-vincadifformine (CHEBI:70507) is a tertiary amino compound (CHEBI:50996) |
| (−)-voacangine (CHEBI:141966) is a tertiary amino compound (CHEBI:50996) |
| (2-Piperidino-3-pyridinyl)methanol (CHEBI:195052) is a tertiary amino compound (CHEBI:50996) |
| (2-Thiomorpholinopyrid-4-yl)methanol (CHEBI:195120) is a tertiary amino compound (CHEBI:50996) |
| (2,6-diamino-4-piperidin-1-ylpyrimidin-1-ium-1-yl) hydrogen sulfate (CHEBI:143426) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:123930) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:111546) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:123787) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:113686) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113730) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124364) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113666) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124473) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:108636) is a tertiary amino compound (CHEBI:50996) |
| (2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:113745) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113796) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113737) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:108702) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:108853) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113849) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:111605) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124325) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113801) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:124584) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:113699) is a tertiary amino compound (CHEBI:50996) |
| (2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:124687) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:111599) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113871) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:108614) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124446) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:111592) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124333) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124540) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:123964) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124362) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124328) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113664) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:108650) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:108661) is a tertiary amino compound (CHEBI:50996) |
| (2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:130966) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113645) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124470) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:108682) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:111583) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:108649) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:108644) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124764) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113840) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:124146) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one (CHEBI:113616) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:108904) is a tertiary amino compound (CHEBI:50996) |
| (2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one (CHEBI:111728) is a tertiary amino compound (CHEBI:50996) |
| (3R)-1,2-didehydro-3-hydroxy-16-methoxy-2,3-dihydrotabersonine (CHEBI:137485) is a tertiary amino compound (CHEBI:50996) |
| (3R)-1,2-didehydro-3-hydroxy-2,3-dihydrotabersonine (CHEBI:139124) is a tertiary amino compound (CHEBI:50996) |
| (3R)-3-hydroxy-2,3-dihydrotabersonine (CHEBI:139122) is a tertiary amino compound (CHEBI:50996) |
| (4aR,10bS)-noroxomaritidine (CHEBI:136560) is a tertiary amino compound (CHEBI:50996) |
| (4aS,10bR)-noroxomaritidine (CHEBI:136557) is a tertiary amino compound (CHEBI:50996) |
| [[4-(diethylamino)phenyl]methylideneamino]urea (CHEBI:114763) is a tertiary amino compound (CHEBI:50996) |
| [[4-(dimethylamino)phenyl]-(2-methylpropoxy)phosphoryl]-(2-fluorophenyl)methanol (CHEBI:107198) is a tertiary amino compound (CHEBI:50996) |
| [99mTc]TRODAT-1 (CHEBI:234508) is a tertiary amino compound (CHEBI:50996) |
| [6-(1-Pyrrolidinyl)-3-pyridinyl]methanol (CHEBI:195087) is a tertiary amino compound (CHEBI:50996) |
| N-methylparoxetine (CHEBI:94536) is a tertiary amino compound (CHEBI:50996) |
| N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amine (CHEBI:121832) is a tertiary amino compound (CHEBI:50996) |
| N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine (CHEBI:145528) is a tertiary amino compound (CHEBI:50996) |
| N-(2-[(2-aminoethyl)(methyl)amino]-5-{[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}phenyl)acetamide (CHEBI:143115) is a tertiary amino compound (CHEBI:50996) |
| N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]-N-methylalanine (CHEBI:48478) is a tertiary amino compound (CHEBI:50996) |
| N-(4-aminobutyl)methamphetamine (CHEBI:235381) is a tertiary amino compound (CHEBI:50996) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide (CHEBI:143123) is a tertiary amino compound (CHEBI:50996) |
| N-(phosphonomethyl)iminodiacetic acid (CHEBI:63485) is a tertiary amino compound (CHEBI:50996) |
| N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide (CHEBI:75125) is a tertiary amino compound (CHEBI:50996) |
| N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide (CHEBI:143112) is a tertiary amino compound (CHEBI:50996) |
| N-{2-[(4-benzylpiperidin-1-yl)methyl]benzimidazol-5-yl}methanesulfonamide (CHEBI:177875) is a tertiary amino compound (CHEBI:50996) |
| N-{2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethyl}-N-propylpropan-1-amine hydrochloride (CHEBI:140905) is a tertiary amino compound (CHEBI:50996) |
| N-{5-[2-{4-[2-(dimethylamino)ethoxy]phenyl}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene}hydroxylamine (CHEBI:131880) is a tertiary amino compound (CHEBI:50996) |
| N-alkylpiperazine (CHEBI:46845) is a tertiary amino compound (CHEBI:50996) |
| N-alkylpyrrolidine (CHEBI:46775) is a tertiary amino compound (CHEBI:50996) |
| N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol (CHEBI:63988) is a tertiary amino compound (CHEBI:50996) |
| N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol (CHEBI:64004) is a tertiary amino compound (CHEBI:50996) |
| N-arylpiperazine (CHEBI:46848) is a tertiary amino compound (CHEBI:50996) |
| N-cyclopropyl-4-[4-(3,4-dichlorophenyl)-2-(1-methylpiperidin-4-yl)-1-propylimidazol-5-yl]pyrimidin-2-amine (CHEBI:47188) is a tertiary amino compound (CHEBI:50996) |
| N-ethyl-1-deoxynojirimycin (CHEBI:167666) is a tertiary amino compound (CHEBI:50996) |
| N-ethyldiethanolamine (CHEBI:132187) is a tertiary amino compound (CHEBI:50996) |
| N-lauryldiethanolamine (CHEBI:229635) is a tertiary amino compound (CHEBI:50996) |
| N-methyl-1-deoxynojirimycin (CHEBI:166564) is a tertiary amino compound (CHEBI:50996) |
| N-methyl-2-(4-methylphenyl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine (CHEBI:123431) is a tertiary amino compound (CHEBI:50996) |
| N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol (CHEBI:64001) is a tertiary amino compound (CHEBI:50996) |
| N-methylnorsalsolinol (CHEBI:89546) is a tertiary amino compound (CHEBI:50996) |
| N-methylpiperazine (CHEBI:46920) is a tertiary amino compound (CHEBI:50996) |
| N-methylproline (CHEBI:90344) is a tertiary amino compound (CHEBI:50996) |
| N-nonyldeoxynojirimycin (CHEBI:76399) is a tertiary amino compound (CHEBI:50996) |
| N-oxyethylpiperidine (CHEBI:48737) is a tertiary amino compound (CHEBI:50996) |
| N,N-bis(2-methoxyethyl)-2-(4-methylphenyl)quinazolin-4-amine (CHEBI:103930) is a tertiary amino compound (CHEBI:50996) |
| N,N-dibutyl-2-(pyridin-4-yl)quinazolin-4-amine (CHEBI:116147) is a tertiary amino compound (CHEBI:50996) |
| N,N-dimethyl-4-nitrosoaniline (CHEBI:59990) is a tertiary amino compound (CHEBI:50996) |
| N,N-dimethyl-β-alanine (CHEBI:138668) is a tertiary amino compound (CHEBI:50996) |
| N,N-dimethylformamide dimethyl acetal (CHEBI:85061) is a tertiary amino compound (CHEBI:50996) |
| N,N-dimethylsphingosine (CHEBI:78759) is a tertiary amino compound (CHEBI:50996) |
| N,N-dipropyl-2-(pyrrolidin-1-yl)quinazolin-4-amine (CHEBI:117900) is a tertiary amino compound (CHEBI:50996) |
| N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (CHEBI:88217) is a tertiary amino compound (CHEBI:50996) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a tertiary amino compound (CHEBI:50996) |
| N4-aminopropylspermidine (CHEBI:83547) is a tertiary amino compound (CHEBI:50996) |
| N4-aminopropylspermine (CHEBI:83554) is a tertiary amino compound (CHEBI:50996) |
| O-desmethylvenlafaxine (CHEBI:83527) is a tertiary amino compound (CHEBI:50996) |
| p-tolylfentanyl (CHEBI:233558) is a tertiary amino compound (CHEBI:50996) |
| para-AmFenHap (CHEBI:233692) is a tertiary amino compound (CHEBI:50996) |
| para-methoxyfentanyl (CHEBI:233771) is a tertiary amino compound (CHEBI:50996) |
| S-2-(dimethylamino)ethyl thiosulfate (CHEBI:53208) is a tertiary amino compound (CHEBI:50996) |
| 1-(1-methylpyrrolidin-2-yl)acetone (CHEBI:84448) is a tertiary amino compound (CHEBI:50996) |
| 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (CHEBI:77796) is a tertiary amino compound (CHEBI:50996) |
| 1-(3,6-dibromocarbazol-9-yl)-3-(dimethylamino)propan-2-ol (CHEBI:78012) is a tertiary amino compound (CHEBI:50996) |
| 1-(4-amino-1,2,5-oxadiazol-3-yl)-3-[[4-(diethylamino)phenyl]methylideneamino]urea (CHEBI:112249) is a tertiary amino compound (CHEBI:50996) |
| 1-(4-chlorophenyl)-2-[4-(4-fluorobenzyl)piperidin-1-yl]ethanol (CHEBI:180651) is a tertiary amino compound (CHEBI:50996) |
| 1-(4-chlorophenyl)-2-[5-(1-pyrrolidinyl)-2-tetrazolyl]ethanone oxime (CHEBI:94146) is a tertiary amino compound (CHEBI:50996) |
| 1-(4-methoxyphenyl)-N-methyl-N-[(3-methyloxetan-3-yl)methyl]methanamine (CHEBI:139160) is a tertiary amino compound (CHEBI:50996) |
| 1-(6-chloro-2-pyridinyl)-4-piperidinamine (CHEBI:92163) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:111472) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:113660) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:113694) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:126970) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:108883) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:130739) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:108852) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:113775) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:111548) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:131263) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:129485) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:126665) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:108725) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:108817) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:124010) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:111607) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:113835) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:124806) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:127012) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:113692) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:127733) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:126919) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:113711) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:113601) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:111766) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:126809) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:108903) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea (CHEBI:127446) is a tertiary amino compound (CHEBI:50996) |
| 1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea (CHEBI:108869) is a tertiary amino compound (CHEBI:50996) |
| 1-[[4-(dimethylamino)phenyl]methylideneamino]-3-(2-furanylmethyl)thiourea (CHEBI:114740) is a tertiary amino compound (CHEBI:50996) |
| 1-[[4-(dimethylamino)phenyl]methylideneamino]-3-(3-methoxypropyl)thiourea (CHEBI:114674) is a tertiary amino compound (CHEBI:50996) |
| 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine (CHEBI:64145) is a tertiary amino compound (CHEBI:50996) |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine (CHEBI:64093) is a tertiary amino compound (CHEBI:50996) |
| 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile (CHEBI:77397) is a tertiary amino compound (CHEBI:50996) |
| 1-[3-[(5-bromo-2-pyridinyl)-butylamino]propyl]-3-[3-(1H-imidazol-5-yl)propyl]thiourea (CHEBI:93647) is a tertiary amino compound (CHEBI:50996) |
| 1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinecarbonitrile (CHEBI:92187) is a tertiary amino compound (CHEBI:50996) |
| 1-[9-ethyl-6-(1-hydroxyiminoethyl)-3-carbazolyl]ethanone oxime (CHEBI:114685) is a tertiary amino compound (CHEBI:50996) |
| 1-[Ethyl-(6-hydrazinylpyridazin-3-yl)amino]propan-2-ol (CHEBI:231131) is a tertiary amino compound (CHEBI:50996) |
| 1-AmidoDihydroMorHap (CHEBI:234424) is a tertiary amino compound (CHEBI:50996) |
| 1-AmidoMorHap (CHEBI:234422) is a tertiary amino compound (CHEBI:50996) |
| 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (CHEBI:77431) is a tertiary amino compound (CHEBI:50996) |
| 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-N-[4-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]-1,4-dihydroquinoline-3-carboxamide (CHEBI:156323) is a tertiary amino compound (CHEBI:50996) |
| 1-ethyl-3-(2-methylbutyl)piperidine (CHEBI:194461) is a tertiary amino compound (CHEBI:50996) |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane (CHEBI:50154) is a tertiary amino compound (CHEBI:50996) |
| 1,1-diethyl-2-hydroxy-3-oxotriazane (CHEBI:77714) is a tertiary amino compound (CHEBI:50996) |
| 1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one (CHEBI:166972) is a tertiary amino compound (CHEBI:50996) |
| 10-deoxysarpagine (CHEBI:16060) is a tertiary amino compound (CHEBI:50996) |
| 10-hydroxycoronaridine (CHEBI:146256) is a tertiary amino compound (CHEBI:50996) |
| 10-hydroxyicajine (CHEBI:132699) is a tertiary amino compound (CHEBI:50996) |
| 11-hydroxyicajine (CHEBI:132700) is a tertiary amino compound (CHEBI:50996) |
| 14-AmidoHerHap (CHEBI:234496) is a tertiary amino compound (CHEBI:50996) |
| 14-AmidoMorHap (CHEBI:234495) is a tertiary amino compound (CHEBI:50996) |
| 14-hydroxyicajine (CHEBI:132670) is a tertiary amino compound (CHEBI:50996) |
| 16-methoxytabersonine (CHEBI:769) is a tertiary amino compound (CHEBI:50996) |
| 17-O-acetylnorajmaline (CHEBI:17384) is a tertiary amino compound (CHEBI:50996) |
| 19-O-acetylhörhammericine (CHEBI:145333) is a tertiary amino compound (CHEBI:50996) |
| 2-(2,3-dihydro-1,4-benzoxazin-4-yl)-8-methoxy-N-(phenylmethyl)-4-quinazolinamine (CHEBI:92009) is a tertiary amino compound (CHEBI:50996) |
| 2-(2,3-dihydro-1,4-benzoxazin-4-yl)-N-(phenylmethyl)-4-pyrimidinamine (CHEBI:92086) is a tertiary amino compound (CHEBI:50996) |
| 2-(2,3-dihydroindol-1-yl)-N-(phenylmethyl)-4-quinazolinamine (CHEBI:93008) is a tertiary amino compound (CHEBI:50996) |
| 2-(2,4-dioxo-1H-pyrimidin-6-yl)-N-[2-(4-morpholinyl)ethyl]acetamide (CHEBI:109275) is a tertiary amino compound (CHEBI:50996) |
| 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile (CHEBI:77733) is a tertiary amino compound (CHEBI:50996) |
| 2-(4-Dimethylaminophenyl)-3-(2-pyridyl)thiazolidin-4-one (CHEBI:149958) is a tertiary amino compound (CHEBI:50996) |
| 2-(4-Dimethylaminophenyl)-3-(6-methyl-2-pyridyl)thiazolidin-4-one (CHEBI:149967) is a tertiary amino compound (CHEBI:50996) |
| 2-(dimethylamino)-cAMP (CHEBI:84598) is a tertiary amino compound (CHEBI:50996) |
| 2-(Dimethylamino)acetonitrile (CHEBI:88381) is a tertiary amino compound (CHEBI:50996) |
| 2-(morpholin-4-yl)ethanol (CHEBI:67144) is a tertiary amino compound (CHEBI:50996) |
| 2-(morpholin-4-yloxy)ethanol (CHEBI:176582) is a tertiary amino compound (CHEBI:50996) |
| 2-(N-ethylanilino)-4-thieno[3,2-d][1,3]thiazinone (CHEBI:116846) is a tertiary amino compound (CHEBI:50996) |
| 2-(piperidin-1-yl)ethanol (CHEBI:61238) is a tertiary amino compound (CHEBI:50996) |
| 2-[(2-Hydroxyethyl)anilino]ethan-1-ol (CHEBI:194838) is a tertiary amino compound (CHEBI:50996) |
| 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol (CHEBI:75722) is a tertiary amino compound (CHEBI:50996) |
| 2-[[2-oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid (CHEBI:93983) is a tertiary amino compound (CHEBI:50996) |
| 2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline (CHEBI:94276) is a tertiary amino compound (CHEBI:50996) |
| 2-[[4-(2-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol (CHEBI:92628) is a tertiary amino compound (CHEBI:50996) |
| 2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenol (CHEBI:92796) is a tertiary amino compound (CHEBI:50996) |
| 2-[[4-(3-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol (CHEBI:93562) is a tertiary amino compound (CHEBI:50996) |
| 2-[[4-(4-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol (CHEBI:93302) is a tertiary amino compound (CHEBI:50996) |
| 2-[[4-(4-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol (CHEBI:92619) is a tertiary amino compound (CHEBI:50996) |
| 2-[[4-(dimethylamino)phenyl]methylidene]-1-cyclohexanone (CHEBI:120567) is a tertiary amino compound (CHEBI:50996) |
| 2-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-5,11-dimethyl-6-pyrimido[4,5-b][1,4]benzodiazepinone (CHEBI:91374) is a tertiary amino compound (CHEBI:50996) |
| 2-[4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenyl-3-pyrazolyl]acetic acid ethyl ester (CHEBI:104951) is a tertiary amino compound (CHEBI:50996) |
| 2-[5-(4-chlorophenyl)-1,3,5-dithiazinan-2-ylidene]-2-diethoxyphosphorylacetonitrile (CHEBI:112378) is a tertiary amino compound (CHEBI:50996) |
| 2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (CHEBI:180905) is a tertiary amino compound (CHEBI:50996) |
| 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate (CHEBI:146221) is a tertiary amino compound (CHEBI:50996) |
| 2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol (CHEBI:64137) is a tertiary amino compound (CHEBI:50996) |
| 2-{[(4-methoxybenzyl)(methyl)amino]methyl}-2-methylpropane-1,3-diol (CHEBI:139163) is a tertiary amino compound (CHEBI:50996) |
| 2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene (CHEBI:194427) is a tertiary amino compound (CHEBI:50996) |
| 2-amino-4-(3-nitrophenyl)-3-cyano-7-(dimethylamino)-4H-chromene (CHEBI:192743) is a tertiary amino compound (CHEBI:50996) |
| 2-amino-4-(cyanomethyl)-6-(N-methylanilino)pyridine-3,5-dicarbonitrile (CHEBI:121400) is a tertiary amino compound (CHEBI:50996) |
| 2-chloro-N,N-dipropylquinazolin-4-amine (CHEBI:94050) is a tertiary amino compound (CHEBI:50996) |
| 2-chloro-2'-hydroxytriethylamine (CHEBI:131420) is a tertiary amino compound (CHEBI:50996) |
| 2-chloro-N-[4-(N-propan-2-ylanilino)phenyl]acetamide (CHEBI:107426) is a tertiary amino compound (CHEBI:50996) |
| 2-cyano-3-[5-(dimethylamino)-2-furanyl]-N-(phenylmethyl)-2-propenamide (CHEBI:107621) is a tertiary amino compound (CHEBI:50996) |
| 2-diethylaminoethanol (CHEBI:52153) is a tertiary amino compound (CHEBI:50996) |
| 2-dimethylaminoethyl chloride (CHEBI:78155) is a tertiary amino compound (CHEBI:50996) |
| 2-Ethyl-N-(2-ethylhexyl)-N-methyl-1-hexanamine (CHEBI:140565) is a tertiary amino compound (CHEBI:50996) |
| 2-Hydroxynevirapine (CHEBI:174695) is a tertiary amino compound (CHEBI:50996) |
| 2-methyl-3-(pyrrolidin-1-yl)-1-[4-(trifluoromethyl)phenyl]propan-1-one (CHEBI:176340) is a tertiary amino compound (CHEBI:50996) |
| 2-Pyrrolidin-1-yl-1,3-thiazole (CHEBI:195065) is a tertiary amino compound (CHEBI:50996) |
| 2-Pyrrolidin-1-ylisonicotinonitrile (CHEBI:195057) is a tertiary amino compound (CHEBI:50996) |
| 2,3,8,9-tetramethoxy-13-methyl-5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene (CHEBI:77060) is a tertiary amino compound (CHEBI:50996) |
| 2,6-diamino-1-{[(3S,4R,5R,6R)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-4-(piperidin-1-yl)pyrimidin-1-ium (CHEBI:143427) is a tertiary amino compound (CHEBI:50996) |
| 2,6-dimethyl-4-tetradecylmorpholine (CHEBI:83370) is a tertiary amino compound (CHEBI:50996) |
| 2,6-dimethyl-4-tridecylmorpholine (CHEBI:83365) is a tertiary amino compound (CHEBI:50996) |
| 2,6-dimethyl-4-undecylmorpholine (CHEBI:83368) is a tertiary amino compound (CHEBI:50996) |
| 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI (CHEBI:174157) is a tertiary amino compound (CHEBI:50996) |
| 20-oxo-5-O-β-mycaminosyltylactone (CHEBI:134191) is a tertiary amino compound (CHEBI:50996) |
| 3-(1-pyrrolidinyl)-5-(trifluoromethyl)pyridine-2-carbothioamide (CHEBI:183680) is a tertiary amino compound (CHEBI:50996) |
| 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate (CHEBI:83284) is a tertiary amino compound (CHEBI:50996) |
| 3-(3,8-dinitro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-1-propanamine (CHEBI:92280) is a tertiary amino compound (CHEBI:50996) |
| 3-(4-chlorophenyl)-6-(1-pyrrolidinyl)-1,2,4,5-tetrazine (CHEBI:108276) is a tertiary amino compound (CHEBI:50996) |
| 3-(4-ethyl-1-piperazinyl)-5-methylpyridazino[3,4-b][1,4]benzoxazine (CHEBI:114240) is a tertiary amino compound (CHEBI:50996) |
| 3-(5-chloro-2-methylphenyl)-6-(2,6-dimethyl-4-morpholinyl)-1H-pyrimidine-2,4-dione (CHEBI:107388) is a tertiary amino compound (CHEBI:50996) |
| 3-(Dimethylamino)-5-(trifluoromethyl)pyridine-2-carbothioamide (CHEBI:194758) is a tertiary amino compound (CHEBI:50996) |
| 3-[(dimethylamino)methyl]-5-[(4-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione (CHEBI:85320) is a tertiary amino compound (CHEBI:50996) |
| 3-[[5,5-dimethyl-3-(4-morpholinyl)-1-cyclohex-2-enylidene]amino]-N,N-dimethylaniline (CHEBI:104142) is a tertiary amino compound (CHEBI:50996) |
| 3-[4-(dimethylamino)phenyl]-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide (CHEBI:119771) is a tertiary amino compound (CHEBI:50996) |
| 3-O-acetyl-4'-O-demethylpapaveroxine (CHEBI:141643) is a tertiary amino compound (CHEBI:50996) |
| 3-O-acetylpapaveroxine (CHEBI:141645) is a tertiary amino compound (CHEBI:50996) |
| 3-O-carboxymethylmorphine (CHEBI:233812) is a tertiary amino compound (CHEBI:50996) |
| 3-allyl-2-[2-(diethylamino)ethoxy]benzaldehyde (CHEBI:86195) is a tertiary amino compound (CHEBI:50996) |
| 3-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-1-methyl-4-(5-methyl-5,6-dihydro-1,4,2-dioxazin-3-yl)-1H-pyrazole-5-sulfonamide (CHEBI:228164) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:126222) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:128076) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:130992) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:128279) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:123671) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:113751) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:127217) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:127206) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:129922) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:124837) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:111816) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:130692) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:130637) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:128261) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:126515) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:108808) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:103733) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:129519) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:128885) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:130556) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea (CHEBI:129653) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:113780) is a tertiary amino compound (CHEBI:50996) |
| 3-cyclohexyl-1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea (CHEBI:111663) is a tertiary amino compound (CHEBI:50996) |
| 3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine (CHEBI:92128) is a tertiary amino compound (CHEBI:50996) |
| 3-Hydroxynevirapine (CHEBI:174697) is a tertiary amino compound (CHEBI:50996) |
| 3-methyl-4'-dimethylaminoazobenzene (CHEBI:76329) is a tertiary amino compound (CHEBI:50996) |
| 3-methylfentanyl (CHEBI:61092) is a tertiary amino compound (CHEBI:50996) |
| 3-Piperidin-1-ylpyridine-2-carbonitrile (CHEBI:195079) is a tertiary amino compound (CHEBI:50996) |
| 3,7-bis(dimethylamino)phenothiazine (CHEBI:78523) is a tertiary amino compound (CHEBI:50996) |
| 3β-(2-diethylaminoethoxy)androst-5-en-17-one (CHEBI:190402) is a tertiary amino compound (CHEBI:50996) |
| 4-(1,3-benzothiazol-2-yl)-5-[4-(N-methylanilino)-3-nitrophenyl]-4-pentenoic acid (CHEBI:109574) is a tertiary amino compound (CHEBI:50996) |
| 4-(2,3-dihydro-1H-indol-1-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine (CHEBI:183454) is a tertiary amino compound (CHEBI:50996) |
| 4-(4-bromophenyl)-2-[4-(2H-tetrazol-5-yl)-1-piperidinyl]thiazole (CHEBI:93190) is a tertiary amino compound (CHEBI:50996) |
| 4-(4-morpholinyl)-N-phenyl-6-(1-pyrrolidinyl)-1,3,5-triazin-2-amine (CHEBI:92394) is a tertiary amino compound (CHEBI:50996) |
| 4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine (CHEBI:93568) is a tertiary amino compound (CHEBI:50996) |
| 4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-(morpholin-4-yl)phenyl]pyrimidin-2-amine (CHEBI:144675) is a tertiary amino compound (CHEBI:50996) |
| 4-(diethylamino)benzaldehyde (CHEBI:86194) is a tertiary amino compound (CHEBI:50996) |
| 4-(diethylamino)but-2-yn-1-ol (CHEBI:144551) is a tertiary amino compound (CHEBI:50996) |
| 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide (CHEBI:125562) is a tertiary amino compound (CHEBI:50996) |
| 4-(Dimethylamino)-3,5-difluorobenzamide (CHEBI:194752) is a tertiary amino compound (CHEBI:50996) |
| 4-(dimethylamino)benzaldehyde (CHEBI:91114) is a tertiary amino compound (CHEBI:50996) |
| 4-(hydroxylamino)-N,N-dimethylaniline (CHEBI:59991) is a tertiary amino compound (CHEBI:50996) |
| 4-[[4-bromo-5-(4-morpholinyl)-2-furanyl]methylideneamino]phenol (CHEBI:114396) is a tertiary amino compound (CHEBI:50996) |
| 4-[2-(diphenylmethoxy)ethyl]-1-[(4-azidophenyl)-methyl]-piperidine (CHEBI:177884) is a tertiary amino compound (CHEBI:50996) |
| 4-[5-(Difluoromethyl)-2-pyridinyl]morpholine (CHEBI:188514) is a tertiary amino compound (CHEBI:50996) |
| 4-[methyl-(4-thiophen-2-yl-2-thiazolyl)amino]phenol (CHEBI:116701) is a tertiary amino compound (CHEBI:50996) |
| 4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol (CHEBI:94539) is a tertiary amino compound (CHEBI:50996) |
| 4-{bis[4-(dimethylamino)phenyl]methyl}phenol (CHEBI:76210) is a tertiary amino compound (CHEBI:50996) |
| 4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide (CHEBI:167204) is a tertiary amino compound (CHEBI:50996) |
| 4-azaleucine (CHEBI:88163) is a tertiary amino compound (CHEBI:50996) |
| 4-bromo-2-phenyl-5-(1-piperidinyl)-3-pyridazinone (CHEBI:122167) is a tertiary amino compound (CHEBI:50996) |
| 4-Carboxynevirapine (CHEBI:169675) is a tertiary amino compound (CHEBI:50996) |
| 4-chloro-5-(dimethylamino)-2-(4-methylphenyl)-3-pyridazinone (CHEBI:111383) is a tertiary amino compound (CHEBI:50996) |
| 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol (CHEBI:90529) is a tertiary amino compound (CHEBI:50996) |
| 4-chlorofentanyl (CHEBI:231308) is a tertiary amino compound (CHEBI:50996) |
| 4-dimethylaminophenol (CHEBI:135941) is a tertiary amino compound (CHEBI:50996) |
| 4-Dimethylaminopyridine (CHEBI:182593) is a tertiary amino compound (CHEBI:50996) |
| 4-diphenylacetoxy-N-methylpiperidine (CHEBI:73469) is a tertiary amino compound (CHEBI:50996) |
| 4-dodecyl-2,5-dimethylmorpholine (CHEBI:83299) is a tertiary amino compound (CHEBI:50996) |
| 4-dodecyl-2,6-dimethylmorpholine (CHEBI:83297) is a tertiary amino compound (CHEBI:50996) |
| 4-fluorofentanyl (CHEBI:61074) is a tertiary amino compound (CHEBI:50996) |
| 4-fluoroisobutyrfentanyl (CHEBI:233683) is a tertiary amino compound (CHEBI:50996) |
| 4-methoxybutyrfentanyl (CHEBI:183351) is a tertiary amino compound (CHEBI:50996) |
| 4-phenylfentanyl (CHEBI:234274) is a tertiary amino compound (CHEBI:50996) |
| 5-(N-methyl-N-propyl)amiloride (CHEBI:138016) is a tertiary amino compound (CHEBI:50996) |
| 5-(1-azepanyl)-1,3,4-thiadiazol-2-amine (CHEBI:107454) is a tertiary amino compound (CHEBI:50996) |
| 5-(2-chloro-6-fluorobenzyl)-6-methyl-2-morpholinopyrimidin-4-ol (CHEBI:183386) is a tertiary amino compound (CHEBI:50996) |
| 5-(2-chlorophenyl)-3-morpholinoisothiazole-4-carbonitrile (CHEBI:228498) is a tertiary amino compound (CHEBI:50996) |
| 5-(3-cyclohexyl-1-pyrrolidinyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazine (CHEBI:94193) is a tertiary amino compound (CHEBI:50996) |
| 5-(4-((1-(2-(diethylamino)ethyl)-5-nitro-1H-benzo[d]imidazol-2-yl)methyl)phenoxy)pentanoic acid (CHEBI:234447) is a tertiary amino compound (CHEBI:50996) |
| 5-(5-chloro-1H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine (CHEBI:90625) is a tertiary amino compound (CHEBI:50996) |
| 5-(dimethylamino)-N-(4-aminobenzyl)naphthalene-1-sulfonamide (CHEBI:59037) is a tertiary amino compound (CHEBI:50996) |
| 5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide (CHEBI:59036) is a tertiary amino compound (CHEBI:50996) |
| 5-[[4-(dimethylamino)phenyl]methylidene]-2-sulfanylidene-1,3-thiazinan-4-one (CHEBI:94033) is a tertiary amino compound (CHEBI:50996) |
| 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate (CHEBI:82814) is a tertiary amino compound (CHEBI:50996) |
| 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (CHEBI:87723) is a tertiary amino compound (CHEBI:50996) |
| 5-[3-(dimethylamino)phenyl]-N-methyl-1,3,4-thiadiazol-2-amine (CHEBI:117246) is a tertiary amino compound (CHEBI:50996) |
| 5-{N-[4-(4-cyanostyryl)phenyl]-N-methylamino}pentanoic acid (CHEBI:63595) is a tertiary amino compound (CHEBI:50996) |
| 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole (CHEBI:71255) is a tertiary amino compound (CHEBI:50996) |
| 5-chloro-N4-(cyclopropylmethyl)-2-methyl-N4-propyl-N6-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine (CHEBI:93069) is a tertiary amino compound (CHEBI:50996) |
| 5-hydroxyvomicine (CHEBI:132702) is a tertiary amino compound (CHEBI:50996) |
| 5-methoxy-N,N-dimethyltryptamine (CHEBI:2086) is a tertiary amino compound (CHEBI:50996) |
| 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine (CHEBI:88318) is a tertiary amino compound (CHEBI:50996) |
| 5-morpholino-2,4(1H,3H)-pyrimidinedione (CHEBI:228718) is a tertiary amino compound (CHEBI:50996) |
| 5,6-didehydrosparteine (CHEBI:143195) is a tertiary amino compound (CHEBI:50996) |
| 6-(dimethylamino)-4,4-diphenylheptan-3-one (CHEBI:167309) is a tertiary amino compound (CHEBI:50996) |
| 6-(dimethylamino)-cPuMP (CHEBI:84627) is a tertiary amino compound (CHEBI:50996) |
| 6-acetylmorphine (CHEBI:2168) is a tertiary amino compound (CHEBI:50996) |
| 6-AcMorHap (CHEBI:234596) is a tertiary amino compound (CHEBI:50996) |
| 6-AmHap (CHEBI:234306) is a tertiary amino compound (CHEBI:50996) |
| 6-hydroxyprotopine (CHEBI:17104) is a tertiary amino compound (CHEBI:50996) |
| 6-PrOxyHap (CHEBI:234597) is a tertiary amino compound (CHEBI:50996) |
| 6,14-AmidoHap (CHEBI:234494) is a tertiary amino compound (CHEBI:50996) |
| 7-(1-azepanyl)-2-oxoheptanal oxime (CHEBI:121126) is a tertiary amino compound (CHEBI:50996) |
| 7-(1-pyrrolidinyl)pyrimido[4,5-d]pyrimidin-4-amine (CHEBI:228711) is a tertiary amino compound (CHEBI:50996) |
| 7-(2-methyl-2,3-dihydroindol-1-yl)-3-(phenylmethyl)triazolo[4,5-d]pyrimidine (CHEBI:114669) is a tertiary amino compound (CHEBI:50996) |
| 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid (CHEBI:77581) is a tertiary amino compound (CHEBI:50996) |
| 7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin (CHEBI:195334) is a tertiary amino compound (CHEBI:50996) |
| 7-hydroxyticlopidine (CHEBI:145218) is a tertiary amino compound (CHEBI:50996) |
| 8-{1-[4-(dimethylamino)phenyl]-3-(pyrrolidin-1-yl)propyl}-5,7-dimethoxy-4-pentyl-2H-chromen-2-one (CHEBI:120918) is a tertiary amino compound (CHEBI:50996) |
| 8-Hydroxynevirapine (CHEBI:174696) is a tertiary amino compound (CHEBI:50996) |
| 8-OH-DPAT (CHEBI:73364) is a tertiary amino compound (CHEBI:50996) |
| 8-PIP-cAMP (CHEBI:145730) is a tertiary amino compound (CHEBI:50996) |
| 9-ethyl-3-carbazolecarboxaldehyde oxime (CHEBI:109047) is a tertiary amino compound (CHEBI:50996) |
| 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one (CHEBI:64028) is a tertiary amino compound (CHEBI:50996) |
| abamine (CHEBI:269574) is a tertiary amino compound (CHEBI:50996) |
| abexinostat (CHEBI:92223) is a tertiary amino compound (CHEBI:50996) |
| ABT-737 (CHEBI:47575) is a tertiary amino compound (CHEBI:50996) |
| acepromazine (CHEBI:44932) is a tertiary amino compound (CHEBI:50996) |
| acetylerucifoline (CHEBI:136464) is a tertiary amino compound (CHEBI:50996) |
| acetylfentanyl (CHEBI:233556) is a tertiary amino compound (CHEBI:50996) |
| aconine (CHEBI:132639) is a tertiary amino compound (CHEBI:50996) |
| acridine orange free base (CHEBI:87346) is a tertiary amino compound (CHEBI:50996) |
| acrylfentanyl (CHEBI:233682) is a tertiary amino compound (CHEBI:50996) |
| ACT-333679 (CHEBI:90848) is a tertiary amino compound (CHEBI:50996) |
| AF-DX 384 (CHEBI:73338) is a tertiary amino compound (CHEBI:50996) |
| afatinib (CHEBI:61390) is a tertiary amino compound (CHEBI:50996) |
| afimoxifene (CHEBI:44616) is a tertiary amino compound (CHEBI:50996) |
| ajaconine (CHEBI:2523) is a tertiary amino compound (CHEBI:50996) |
| akuammicine (CHEBI:70499) is a tertiary amino compound (CHEBI:50996) |
| alangimarckine (CHEBI:2536) is a tertiary amino compound (CHEBI:50996) |
| alcaftadine (CHEBI:71023) is a tertiary amino compound (CHEBI:50996) |
| alfentanil (CHEBI:2569) is a tertiary amino compound (CHEBI:50996) |
| allocryptopine (CHEBI:17390) is a tertiary amino compound (CHEBI:50996) |
| alvespimycin (CHEBI:65324) is a tertiary amino compound (CHEBI:50996) |
| alvocidib (CHEBI:47344) is a tertiary amino compound (CHEBI:50996) |
| AMG-925 (CHEBI:145537) is a tertiary amino compound (CHEBI:50996) |
| aminophenazone (CHEBI:160246) is a tertiary amino compound (CHEBI:50996) |
| amiodarone (CHEBI:2663) is a tertiary amino compound (CHEBI:50996) |
| amitraz (CHEBI:2665) is a tertiary amino compound (CHEBI:50996) |
| amodiaquine (CHEBI:2674) is a tertiary amino compound (CHEBI:50996) |
| amorolfine (CHEBI:599440) is a tertiary amino compound (CHEBI:50996) |
| ankorine (CHEBI:2740) is a tertiary amino compound (CHEBI:50996) |
| antalarmin (CHEBI:139557) is a tertiary amino compound (CHEBI:50996) |
| antazoline (CHEBI:84115) is a tertiary amino compound (CHEBI:50996) |
| AP20187 (CHEBI:136847) is a tertiary amino compound (CHEBI:50996) |
| aporphine (CHEBI:35643) is a tertiary amino compound (CHEBI:50996) |
| AS1842856 (CHEBI:145800) is a tertiary amino compound (CHEBI:50996) |
| atglistatin (CHEBI:228145) is a tertiary amino compound (CHEBI:50996) |
| atrasentan (CHEBI:135810) is a tertiary amino compound (CHEBI:50996) |
| auramine O free base (CHEBI:51874) is a tertiary amino compound (CHEBI:50996) |
| auricin (CHEBI:156301) is a tertiary amino compound (CHEBI:50996) |
| azaperone (CHEBI:88301) is a tertiary amino compound (CHEBI:50996) |
| AZD-1152 (CHEBI:91367) is a tertiary amino compound (CHEBI:50996) |
| AZD-8055 (CHEBI:91329) is a tertiary amino compound (CHEBI:50996) |
| AZD1080 (CHEBI:167651) is a tertiary amino compound (CHEBI:50996) |
| AZD3463 (CHEBI:167653) is a tertiary amino compound (CHEBI:50996) |
| azelastine (CHEBI:2950) is a tertiary amino compound (CHEBI:50996) |
| azodopa (CHEBI:195323) is a tertiary amino compound (CHEBI:50996) |
| AZT-1152 (CHEBI:167636) is a tertiary amino compound (CHEBI:50996) |
| barbinine (CHEBI:2992) is a tertiary amino compound (CHEBI:50996) |
| BDA-366 (CHEBI:86325) is a tertiary amino compound (CHEBI:50996) |
| bedaquiline (CHEBI:72292) is a tertiary amino compound (CHEBI:50996) |
| belladine (CHEBI:3005) is a tertiary amino compound (CHEBI:50996) |
| benfluralin (CHEBI:132878) is a tertiary amino compound (CHEBI:50996) |
| benzatropine (CHEBI:3048) is a tertiary amino compound (CHEBI:50996) |
| benzoylaconine (CHEBI:132633) is a tertiary amino compound (CHEBI:50996) |
| benzoylhypaconine (CHEBI:132634) is a tertiary amino compound (CHEBI:50996) |
| benzoylmesaconine (CHEBI:132630) is a tertiary amino compound (CHEBI:50996) |
| benzydamine (CHEBI:94563) is a tertiary amino compound (CHEBI:50996) |
| BI-2536 (CHEBI:49868) is a tertiary amino compound (CHEBI:50996) |
| biperiden (CHEBI:3112) is a tertiary amino compound (CHEBI:50996) |
| bosutinib (CHEBI:39112) is a tertiary amino compound (CHEBI:50996) |
| bromazine (CHEBI:59177) is a tertiary amino compound (CHEBI:50996) |
| bromhexine (CHEBI:77032) is a tertiary amino compound (CHEBI:50996) |
| butonitazene (CHEBI:234364) is a tertiary amino compound (CHEBI:50996) |
| butyrfentanyl (CHEBI:233557) is a tertiary amino compound (CHEBI:50996) |
| buzepide (CHEBI:157619) is a tertiary amino compound (CHEBI:50996) |
| calyculin A (CHEBI:41791) is a tertiary amino compound (CHEBI:50996) |
| caracurine VII (CHEBI:141968) is a tertiary amino compound (CHEBI:50996) |
| carbinoxamine (CHEBI:3398) is a tertiary amino compound (CHEBI:50996) |
| carfentanil (CHEBI:61084) is a tertiary amino compound (CHEBI:50996) |
| carmoxirole (CHEBI:64200) is a tertiary amino compound (CHEBI:50996) |
| cassaidine (CHEBI:3453) is a tertiary amino compound (CHEBI:50996) |
| cassaine (CHEBI:3454) is a tertiary amino compound (CHEBI:50996) |
| catharanthine (CHEBI:3469) is a tertiary amino compound (CHEBI:50996) |
| caulophine (CHEBI:65604) is a tertiary amino compound (CHEBI:50996) |
| CBL0137 (CHEBI:138650) is a tertiary amino compound (CHEBI:50996) |
| cephalotaxine (CHEBI:3540) is a tertiary amino compound (CHEBI:50996) |
| chasmanine (CHEBI:132641) is a tertiary amino compound (CHEBI:50996) |
| chlorambucil (CHEBI:28830) is a tertiary amino compound (CHEBI:50996) |
| chloropyrilene (CHEBI:135246) is a tertiary amino compound (CHEBI:50996) |
| chloroquine (CHEBI:3638) is a tertiary amino compound (CHEBI:50996) |
| chlorphenamine (CHEBI:52010) is a tertiary amino compound (CHEBI:50996) |
| chlorprothixene (CHEBI:3651) is a tertiary amino compound (CHEBI:50996) |
| chlortetracycline (CHEBI:27644) is a tertiary amino compound (CHEBI:50996) |
| cinaciguat (CHEBI:142433) is a tertiary amino compound (CHEBI:50996) |
| cinanserin (CHEBI:145999) is a tertiary amino compound (CHEBI:50996) |
| cinchocaine (CHEBI:247956) is a tertiary amino compound (CHEBI:50996) |
| citrinalin B (CHEBI:70404) is a tertiary amino compound (CHEBI:50996) |
| clofedanol (CHEBI:135207) is a tertiary amino compound (CHEBI:50996) |
| clopidogrel carboxylic acid (CHEBI:83504) is a tertiary amino compound (CHEBI:50996) |
| clorgyline (CHEBI:3763) is a tertiary amino compound (CHEBI:50996) |
| CM-272 (CHEBI:229970) is a tertiary amino compound (CHEBI:50996) |
| cocaine (CHEBI:27958) is a tertiary amino compound (CHEBI:50996) |
| colforsin daropate (CHEBI:166826) is a tertiary amino compound (CHEBI:50996) |
| conessine (CHEBI:27965) is a tertiary amino compound (CHEBI:50996) |
| copanlisib (CHEBI:173077) is a tertiary amino compound (CHEBI:50996) |
| cortistatins (CHEBI:67169) is a tertiary amino compound (CHEBI:50996) |
| crassicauline A (CHEBI:132638) is a tertiary amino compound (CHEBI:50996) |
| crenolanib (CHEBI:145365) is a tertiary amino compound (CHEBI:50996) |
| CT-179 (CHEBI:234076) is a tertiary amino compound (CHEBI:50996) |
| cyclopentolate (CHEBI:4024) is a tertiary amino compound (CHEBI:50996) |
| cyclopropylfentanyl (CHEBI:233606) is a tertiary amino compound (CHEBI:50996) |
| cycrimine (CHEBI:59692) is a tertiary amino compound (CHEBI:50996) |
| Cyprofuram (CHEBI:82054) is a tertiary amino compound (CHEBI:50996) |
| cyverine (CHEBI:135027) is a tertiary amino compound (CHEBI:50996) |
| dacomitinib (CHEBI:132268) is a tertiary amino compound (CHEBI:50996) |
| dalfopristin (CHEBI:4309) is a tertiary amino compound (CHEBI:50996) |
| dasatinib (anhydrous) (CHEBI:49375) is a tertiary amino compound (CHEBI:50996) |
| dauricine (CHEBI:4331) is a tertiary amino compound (CHEBI:50996) |
| DC_517 (CHEBI:229971) is a tertiary amino compound (CHEBI:50996) |
| dehydrojacoline (CHEBI:136495) is a tertiary amino compound (CHEBI:50996) |
| dehydrojaconine (CHEBI:136460) is a tertiary amino compound (CHEBI:50996) |
| delgocitinib (CHEBI:167600) is a tertiary amino compound (CHEBI:50996) |
| deltaline (CHEBI:4387) is a tertiary amino compound (CHEBI:50996) |
| deoxyaconitine (CHEBI:132636) is a tertiary amino compound (CHEBI:50996) |
| Dermacozine D (CHEBI:209129) is a tertiary amino compound (CHEBI:50996) |
| desacetyldoronine (CHEBI:136487) is a tertiary amino compound (CHEBI:50996) |
| devapamil (CHEBI:34673) is a tertiary amino compound (CHEBI:50996) |
| DiAmHap (CHEBI:234598) is a tertiary amino compound (CHEBI:50996) |
| Diethatyl-ethyl (CHEBI:82178) is a tertiary amino compound (CHEBI:50996) |
| dihydro-β-erythroidine (CHEBI:34705) is a tertiary amino compound (CHEBI:50996) |
| dimantine (CHEBI:135258) is a tertiary amino compound (CHEBI:50996) |
| dimepyrolimet (CHEBI:233598) is a tertiary amino compound (CHEBI:50996) |
| dimethirimol (CHEBI:81958) is a tertiary amino compound (CHEBI:50996) |
| Dimethylaminopropyl Methacrylamide (CHEBI:189271) is a tertiary amino compound (CHEBI:50996) |
| dimethylphosphatidylethanolamine 32:0 (CHEBI:134486) is a tertiary amino compound (CHEBI:50996) |
| dimethylphosphatidylethanolamine 34:1 (CHEBI:167195) is a tertiary amino compound (CHEBI:50996) |
| dimethylphosphatidylethanolamine 36:3 (CHEBI:167196) is a tertiary amino compound (CHEBI:50996) |
| dinaciclib (CHEBI:95060) is a tertiary amino compound (CHEBI:50996) |
| diphenhydramine (CHEBI:4636) is a tertiary amino compound (CHEBI:50996) |
| DiPrOxyHap (CHEBI:234599) is a tertiary amino compound (CHEBI:50996) |
| dipyridamole (CHEBI:4653) is a tertiary amino compound (CHEBI:50996) |
| disopyramide (CHEBI:4657) is a tertiary amino compound (CHEBI:50996) |
| dithiadene (CHEBI:167625) is a tertiary amino compound (CHEBI:50996) |
| DMH4 (CHEBI:229963) is a tertiary amino compound (CHEBI:50996) |
| dodemorph (CHEBI:81960) is a tertiary amino compound (CHEBI:50996) |
| dofetilide (CHEBI:4681) is a tertiary amino compound (CHEBI:50996) |
| Dopastin (CHEBI:224074) is a tertiary amino compound (CHEBI:50996) |
| dorzagliatin (CHEBI:234514) is a tertiary amino compound (CHEBI:50996) |
| doxepin (CHEBI:4710) is a tertiary amino compound (CHEBI:50996) |
| DPI2 (CHEBI:176422) is a tertiary amino compound (CHEBI:50996) |
| dregamine (CHEBI:141897) is a tertiary amino compound (CHEBI:50996) |
| dronedarone (CHEBI:50659) is a tertiary amino compound (CHEBI:50996) |
| DS-1-38 (CHEBI:231606) is a tertiary amino compound (CHEBI:50996) |
| dWIZ-2 (CHEBI:233640) is a tertiary amino compound (CHEBI:50996) |
| ecgonine methyl ester (CHEBI:31529) is a tertiary amino compound (CHEBI:50996) |
| ecgonone methyl ester (CHEBI:67115) is a tertiary amino compound (CHEBI:50996) |
| edoxaban (CHEBI:85973) is a tertiary amino compound (CHEBI:50996) |
| efinaconazole (CHEBI:82718) is a tertiary amino compound (CHEBI:50996) |
| elacestrant (CHEBI:229213) is a tertiary amino compound (CHEBI:50996) |
| Elaiomycin D (CHEBI:189249) is a tertiary amino compound (CHEBI:50996) |
| eltoprazine (CHEBI:234413) is a tertiary amino compound (CHEBI:50996) |
| Emicerfont (CHEBI:177452) is a tertiary amino compound (CHEBI:50996) |
| ergometrine (CHEBI:4822) is a tertiary amino compound (CHEBI:50996) |
| erucifoline (CHEBI:136462) is a tertiary amino compound (CHEBI:50996) |
| ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate (CHEBI:77817) is a tertiary amino compound (CHEBI:50996) |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid (CHEBI:30740) is a tertiary amino compound (CHEBI:50996) |
| ethylisopropylamiloride (CHEBI:136538) is a tertiary amino compound (CHEBI:50996) |
| etodesnitazene (CHEBI:234368) is a tertiary amino compound (CHEBI:50996) |
| etonitazene (CHEBI:234361) is a tertiary amino compound (CHEBI:50996) |
| evofosfamide (CHEBI:231678) is a tertiary amino compound (CHEBI:50996) |
| finafloxacin (CHEBI:85176) is a tertiary amino compound (CHEBI:50996) |
| flavoxate (CHEBI:5088) is a tertiary amino compound (CHEBI:50996) |
| floridanine (CHEBI:136491) is a tertiary amino compound (CHEBI:50996) |
| florosenine (CHEBI:136490) is a tertiary amino compound (CHEBI:50996) |
| flunitazene (CHEBI:234366) is a tertiary amino compound (CHEBI:50996) |
| flupyradifurone (CHEBI:133997) is a tertiary amino compound (CHEBI:50996) |
| flurazepam (CHEBI:5128) is a tertiary amino compound (CHEBI:50996) |
| foresaconitine (CHEBI:132637) is a tertiary amino compound (CHEBI:50996) |
| foresticine (CHEBI:132642) is a tertiary amino compound (CHEBI:50996) |
| furanylfentanyl (CHEBI:233684) is a tertiary amino compound (CHEBI:50996) |
| galanthamine (CHEBI:42944) is a tertiary amino compound (CHEBI:50996) |
| GANT61 (CHEBI:140908) is a tertiary amino compound (CHEBI:50996) |
| GDC-0326 (CHEBI:229938) is a tertiary amino compound (CHEBI:50996) |
| gefitinib (CHEBI:49668) is a tertiary amino compound (CHEBI:50996) |
| givinostat (CHEBI:94187) is a tertiary amino compound (CHEBI:50996) |
| glyphosine (CHEBI:63484) is a tertiary amino compound (CHEBI:50996) |
| GND (CHEBI:233670) is a tertiary amino compound (CHEBI:50996) |
| GNE (CHEBI:233655) is a tertiary amino compound (CHEBI:50996) |
| gramine (CHEBI:28948) is a tertiary amino compound (CHEBI:50996) |
| granisetron (CHEBI:5537) is a tertiary amino compound (CHEBI:50996) |
| GSK-923295 (CHEBI:234356) is a tertiary amino compound (CHEBI:50996) |
| GSK-J1 (CHEBI:131152) is a tertiary amino compound (CHEBI:50996) |
| GSK-J4 (CHEBI:95077) is a tertiary amino compound (CHEBI:50996) |
| GSK2879552 (CHEBI:176334) is a tertiary amino compound (CHEBI:50996) |
| guattegaumerine (CHEBI:5568) is a tertiary amino compound (CHEBI:50996) |
| GYS32661 (CHEBI:197341) is a tertiary amino compound (CHEBI:50996) |
| HA15 (CHEBI:132781) is a tertiary amino compound (CHEBI:50996) |
| herquline A (CHEBI:229724) is a tertiary amino compound (CHEBI:50996) |
| herquline B (CHEBI:66012) is a tertiary amino compound (CHEBI:50996) |
| herquline C (CHEBI:229729) is a tertiary amino compound (CHEBI:50996) |
| hesperadin (CHEBI:70726) is a tertiary amino compound (CHEBI:50996) |
| hispidospermidin (CHEBI:66017) is a tertiary amino compound (CHEBI:50996) |
| hokbusine A (CHEBI:132632) is a tertiary amino compound (CHEBI:50996) |
| hookerianamide K (CHEBI:66023) is a tertiary amino compound (CHEBI:50996) |
| hörhammericine (CHEBI:5765) is a tertiary amino compound (CHEBI:50996) |
| HTH-01-015 (CHEBI:234378) is a tertiary amino compound (CHEBI:50996) |
| hydroxychloroquine (CHEBI:5801) is a tertiary amino compound (CHEBI:50996) |
| hydroxyethylflurazepam (CHEBI:143437) is a tertiary amino compound (CHEBI:50996) |
| hypaconine (CHEBI:132644) is a tertiary amino compound (CHEBI:50996) |
| ibogamine (CHEBI:5853) is a tertiary amino compound (CHEBI:50996) |
| icaceine (CHEBI:5858) is a tertiary amino compound (CHEBI:50996) |
| icajine (CHEBI:132668) is a tertiary amino compound (CHEBI:50996) |
| ICR 340 (free base) (CHEBI:189532) is a tertiary amino compound (CHEBI:50996) |
| iloperidone (CHEBI:65173) is a tertiary amino compound (CHEBI:50996) |
| iptacopan (CHEBI:229652) is a tertiary amino compound (CHEBI:50996) |
| irinotecan (CHEBI:80630) is a tertiary amino compound (CHEBI:50996) |
| isobrucine (CHEBI:132660) is a tertiary amino compound (CHEBI:50996) |
| isoflucypram (CHEBI:228225) is a tertiary amino compound (CHEBI:50996) |
| isopseudostrychnine (CHEBI:132664) is a tertiary amino compound (CHEBI:50996) |
| isoretuline (CHEBI:141914) is a tertiary amino compound (CHEBI:50996) |
| isosarcodine (CHEBI:228286) is a tertiary amino compound (CHEBI:50996) |
| isostrychnine (CHEBI:132659) is a tertiary amino compound (CHEBI:50996) |
| isotalatizidine (CHEBI:132628) is a tertiary amino compound (CHEBI:50996) |
| isothipendyl (CHEBI:135183) is a tertiary amino compound (CHEBI:50996) |
| Isothipendyl hydrochloride (CHEBI:31734) is a tertiary amino compound (CHEBI:50996) |
| isotodesnitazene (CHEBI:234367) is a tertiary amino compound (CHEBI:50996) |
| isotonitazene (CHEBI:234360) is a tertiary amino compound (CHEBI:50996) |
| ivabradine (CHEBI:85966) is a tertiary amino compound (CHEBI:50996) |
| jacoline (CHEBI:136452) is a tertiary amino compound (CHEBI:50996) |
| jaconine (CHEBI:136455) is a tertiary amino compound (CHEBI:50996) |
| jacozine (CHEBI:136458) is a tertiary amino compound (CHEBI:50996) |
| Jietacin A (CHEBI:222302) is a tertiary amino compound (CHEBI:50996) |
| josamycin (CHEBI:31739) is a tertiary amino compound (CHEBI:50996) |
| karakoline (CHEBI:6113) is a tertiary amino compound (CHEBI:50996) |
| ketotifen (CHEBI:92511) is a tertiary amino compound (CHEBI:50996) |
| KN-93 (CHEBI:91460) is a tertiary amino compound (CHEBI:50996) |
| komodoquinone A (CHEBI:167003) is a tertiary amino compound (CHEBI:50996) |
| Ku-0063794 (CHEBI:85572) is a tertiary amino compound (CHEBI:50996) |
| KU-60019 (CHEBI:228206) is a tertiary amino compound (CHEBI:50996) |
| L-778,123 (free base) (CHEBI:180478) is a tertiary amino compound (CHEBI:50996) |
| leucomethylene blue (CHEBI:134180) is a tertiary amino compound (CHEBI:50996) |
| levacetylmethadol (CHEBI:6441) is a tertiary amino compound (CHEBI:50996) |
| lidocaine (CHEBI:6456) is a tertiary amino compound (CHEBI:50996) |
| lissoclibadin 1 (CHEBI:66579) is a tertiary amino compound (CHEBI:50996) |
| lissoclibadin 2 (CHEBI:66580) is a tertiary amino compound (CHEBI:50996) |
| lissoclibadin 3 (CHEBI:66581) is a tertiary amino compound (CHEBI:50996) |
| LLNL-02 (CHEBI:180652) is a tertiary amino compound (CHEBI:50996) |
| lofentanyl (CHEBI:61095) is a tertiary amino compound (CHEBI:50996) |
| lofepramine (CHEBI:47782) is a tertiary amino compound (CHEBI:50996) |
| LRRK2-IN-1 (CHEBI:78413) is a tertiary amino compound (CHEBI:50996) |
| LSM-10523 (CHEBI:99144) is a tertiary amino compound (CHEBI:50996) |
| LSM-11217 (CHEBI:99838) is a tertiary amino compound (CHEBI:50996) |
| LSM-11916 (CHEBI:100542) is a tertiary amino compound (CHEBI:50996) |
| LSM-11987 (CHEBI:100613) is a tertiary amino compound (CHEBI:50996) |
| LSM-12226 (CHEBI:100852) is a tertiary amino compound (CHEBI:50996) |
| LSM-12795 (CHEBI:101432) is a tertiary amino compound (CHEBI:50996) |
| LSM-18554 (CHEBI:107200) is a tertiary amino compound (CHEBI:50996) |
| LSM-6299 (CHEBI:95055) is a tertiary amino compound (CHEBI:50996) |
| LSM-8542 (CHEBI:97163) is a tertiary amino compound (CHEBI:50996) |
| LSM-9861 (CHEBI:98482) is a tertiary amino compound (CHEBI:50996) |
| lucidine B (CHEBI:6556) is a tertiary amino compound (CHEBI:50996) |
| LY-310762 (CHEBI:140937) is a tertiary amino compound (CHEBI:50996) |
| LY-367,265 (CHEBI:183634) is a tertiary amino compound (CHEBI:50996) |
| Maniwamycin B (CHEBI:200432) is a tertiary amino compound (CHEBI:50996) |
| Maniwamycin C (CHEBI:225442) is a tertiary amino compound (CHEBI:50996) |
| Maniwamycin D (CHEBI:225447) is a tertiary amino compound (CHEBI:50996) |
| Maniwamycin E (CHEBI:225450) is a tertiary amino compound (CHEBI:50996) |
| Maniwamycin F (CHEBI:225455) is a tertiary amino compound (CHEBI:50996) |
| martefragin A (CHEBI:66681) is a tertiary amino compound (CHEBI:50996) |
| mesaconine (CHEBI:132645) is a tertiary amino compound (CHEBI:50996) |
| mesoridazine (CHEBI:6780) is a tertiary amino compound (CHEBI:50996) |
| methiothepin (CHEBI:64203) is a tertiary amino compound (CHEBI:50996) |
| methyl N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]-N-methylalaninate (CHEBI:48477) is a tertiary amino compound (CHEBI:50996) |
| methyl red (CHEBI:49770) is a tertiary amino compound (CHEBI:50996) |
| Methyl violet 2B free base (CHEBI:90110) is a tertiary amino compound (CHEBI:50996) |
| methyllycaconitine (CHEBI:43931) is a tertiary amino compound (CHEBI:50996) |
| methylthioadenosine-DADMe immucillin-A (CHEBI:234322) is a tertiary amino compound (CHEBI:50996) |
| metoclopramide (CHEBI:107736) is a tertiary amino compound (CHEBI:50996) |
| metodesnitazene (CHEBI:234370) is a tertiary amino compound (CHEBI:50996) |
| metonitazene (CHEBI:234362) is a tertiary amino compound (CHEBI:50996) |
| midafotel (CHEBI:180900) is a tertiary amino compound (CHEBI:50996) |
| mifepristone (CHEBI:50692) is a tertiary amino compound (CHEBI:50996) |
| miglustat (CHEBI:50381) is a tertiary amino compound (CHEBI:50996) |
| MLI-2 (CHEBI:132484) is a tertiary amino compound (CHEBI:50996) |
| MMP9 inhibitor I (CHEBI:138840) is a tertiary amino compound (CHEBI:50996) |
| momelotinib (CHEBI:91407) is a tertiary amino compound (CHEBI:50996) |
| monodansylcadaverine (CHEBI:52007) is a tertiary amino compound (CHEBI:50996) |
| mopidamol (CHEBI:135682) is a tertiary amino compound (CHEBI:50996) |
| MorHap (CHEBI:234595) is a tertiary amino compound (CHEBI:50996) |
| morphine (CHEBI:17303) is a tertiary amino compound (CHEBI:50996) |
| morphine-6-hemisuccinate (CHEBI:233811) is a tertiary amino compound (CHEBI:50996) |
| muramine (CHEBI:194523) is a tertiary amino compound (CHEBI:50996) |
| mycophenolate mofetil (CHEBI:8764) is a tertiary amino compound (CHEBI:50996) |
| N-(3-chloro-4-fluorophenyl)-6-[4-(diethylaminomethyl)-1-piperidinyl]-4-pyrimido[5,4-d]pyrimidinamine (CHEBI:92855) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:111801) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:113618) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:111545) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:113641) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124289) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124902) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124117) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:123846) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124737) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124666) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:108672) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:123735) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:95395) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124464) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:113845) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124278) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:113678) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:113866) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124850) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124169) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124370) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124826) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124318) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:123803) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:124176) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:111602) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:111677) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:111789) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:111745) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:124883) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124602) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124701) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:124096) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:108920) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:124497) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:103735) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:111790) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:111627) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:111775) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:113813) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:111727) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:108671) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:113721) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:113565) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide (CHEBI:124704) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide (CHEBI:108668) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide (CHEBI:111577) is a tertiary amino compound (CHEBI:50996) |
| N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide (CHEBI:124123) is a tertiary amino compound (CHEBI:50996) |
| N-[[4-(diethylamino)phenyl]methylideneamino]carbamic acid tert-butyl ester (CHEBI:119859) is a tertiary amino compound (CHEBI:50996) |
| N-[1-(4-butylphenyl)ethylideneamino]-2-methyl-6-(4-morpholinyl)-4-pyrimidinamine (CHEBI:105268) is a tertiary amino compound (CHEBI:50996) |
| N-[1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinyl]carbamic acid tert-butyl ester (CHEBI:93048) is a tertiary amino compound (CHEBI:50996) |
| N-[3-(N-ethylanilino)propyl]-2,4-dimethyl-6-oxo-3-pyrancarboxamide (CHEBI:116949) is a tertiary amino compound (CHEBI:50996) |
| N-[4-(diethylamino)phenyl]-N'-phenylurea (CHEBI:190671) is a tertiary amino compound (CHEBI:50996) |
| N-Ethyl-N-methyl-1,2-ethanediamine (CHEBI:140560) is a tertiary amino compound (CHEBI:50996) |
| N-methyl-(2-thiomorpholinopyrid-4-yl)methylamine (CHEBI:194982) is a tertiary amino compound (CHEBI:50996) |
| N-Methyldioctylamine (CHEBI:176815) is a tertiary amino compound (CHEBI:50996) |
| N,N-Diisopropylethylamine (DIPEA) (CHEBI:193590) is a tertiary amino compound (CHEBI:50996) |
| N,N-dimethyl-1-Dodecanamine (CHEBI:229425) is a tertiary amino compound (CHEBI:50996) |
| N,N-dimethyl-3-phenyl-3-(2-pyridinyl)-1-propanamine (CHEBI:91591) is a tertiary amino compound (CHEBI:50996) |
| N,N-Dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine oxide (CHEBI:181459) is a tertiary amino compound (CHEBI:50996) |
| N,N-dimethyl-4-[[6-(3-pyridinyl)-3,4-dihydro-2H-pyridin-5-ylidene]methyl]aniline (CHEBI:92467) is a tertiary amino compound (CHEBI:50996) |
| N'-(3-chlorophenyl)-N,N-dimethyl-N'-phenylpropane-1,3-diamine (CHEBI:125599) is a tertiary amino compound (CHEBI:50996) |
| N2,N4-bis[[4-(dimethylamino)phenyl]methylideneamino]-3,5-dimethyl-1H-pyrrole-2,4-dicarboxamide (CHEBI:112763) is a tertiary amino compound (CHEBI:50996) |
| N4-(2-furanylmethyl)-N2-(3-methylphenyl)-6-(4-morpholinyl)-1,3,5-triazine-2,4-diamine (CHEBI:114834) is a tertiary amino compound (CHEBI:50996) |
| N4-ethyl-N6,1,2-trimethyl-N4-phenylpyrimidin-1-ium-4,6-diamine (CHEBI:92332) is a tertiary amino compound (CHEBI:50996) |
| N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine (CHEBI:107511) is a tertiary amino compound (CHEBI:50996) |
| nafadotride (CHEBI:64191) is a tertiary amino compound (CHEBI:50996) |
| navitoclax (CHEBI:131174) is a tertiary amino compound (CHEBI:50996) |
| naxagolide (CHEBI:177372) is a tertiary amino compound (CHEBI:50996) |
| nelfinavir (CHEBI:7496) is a tertiary amino compound (CHEBI:50996) |
| neojiangyouaconitine (CHEBI:132635) is a tertiary amino compound (CHEBI:50996) |
| neoline (CHEBI:132629) is a tertiary amino compound (CHEBI:50996) |
| neutral red base (CHEBI:86372) is a tertiary amino compound (CHEBI:50996) |
| nile red (CHEBI:52169) is a tertiary amino compound (CHEBI:50996) |
| Nitrosoxacin A (CHEBI:199152) is a tertiary amino compound (CHEBI:50996) |
| Nitrosoxacin B (CHEBI:226222) is a tertiary amino compound (CHEBI:50996) |
| Nitrosoxacin C (CHEBI:212898) is a tertiary amino compound (CHEBI:50996) |
| nizatidine (CHEBI:7601) is a tertiary amino compound (CHEBI:50996) |
| NNC 55-0396 (free base) (CHEBI:194337) is a tertiary amino compound (CHEBI:50996) |
| NOC-5 (CHEBI:149521) is a tertiary amino compound (CHEBI:50996) |
| nogalamycin (CHEBI:44504) is a tertiary amino compound (CHEBI:50996) |
| norajmaline (CHEBI:7621) is a tertiary amino compound (CHEBI:50996) |
| noribogaine (CHEBI:146264) is a tertiary amino compound (CHEBI:50996) |
| nothramicin (CHEBI:66638) is a tertiary amino compound (CHEBI:50996) |
| novacine (CHEBI:132669) is a tertiary amino compound (CHEBI:50996) |
| NPD6433 (CHEBI:195528) is a tertiary amino compound (CHEBI:50996) |
| NSC 23766 (CHEBI:144984) is a tertiary amino compound (CHEBI:50996) |
| NTA (CHEBI:39054) is a tertiary amino compound (CHEBI:50996) |
| ocfentanyl (CHEBI:183384) is a tertiary amino compound (CHEBI:50996) |
| ohmefentanyl (CHEBI:194294) is a tertiary amino compound (CHEBI:50996) |
| onetine (CHEBI:136473) is a tertiary amino compound (CHEBI:50996) |
| oripavine (CHEBI:7782) is a tertiary amino compound (CHEBI:50996) |
| orphenadrine (CHEBI:7789) is a tertiary amino compound (CHEBI:50996) |
| oryzalin (CHEBI:73163) is a tertiary amino compound (CHEBI:50996) |
| osimertinib (CHEBI:90943) is a tertiary amino compound (CHEBI:50996) |
| otosenine (CHEBI:136467) is a tertiary amino compound (CHEBI:50996) |
| oxolucidine B (CHEBI:7849) is a tertiary amino compound (CHEBI:50996) |
| oxyacanthine (CHEBI:7853) is a tertiary amino compound (CHEBI:50996) |
| oxybuprocaine (CHEBI:309594) is a tertiary amino compound (CHEBI:50996) |
| oxybutynin (CHEBI:7856) is a tertiary amino compound (CHEBI:50996) |
| oxypendyl (CHEBI:135565) is a tertiary amino compound (CHEBI:50996) |
| PA-16-0081C (CHEBI:144673) is a tertiary amino compound (CHEBI:50996) |
| pachyaximine A (CHEBI:228289) is a tertiary amino compound (CHEBI:50996) |
| palbociclib (CHEBI:85993) is a tertiary amino compound (CHEBI:50996) |
| parbenate (CHEBI:52073) is a tertiary amino compound (CHEBI:50996) |
| pateamine (CHEBI:134184) is a tertiary amino compound (CHEBI:50996) |
| PD173074 (CHEBI:63448) is a tertiary amino compound (CHEBI:50996) |
| PDGF receptor tyrosine kinase inhibitor III (CHEBI:143127) is a tertiary amino compound (CHEBI:50996) |
| pemafibrate (CHEBI:228365) is a tertiary amino compound (CHEBI:50996) |
| Perzinfotel (CHEBI:177764) is a tertiary amino compound (CHEBI:50996) |
| pethidine (CHEBI:6754) is a tertiary amino compound (CHEBI:50996) |
| PF-3758309 (CHEBI:93751) is a tertiary amino compound (CHEBI:50996) |
| PF-956980 (CHEBI:144672) is a tertiary amino compound (CHEBI:50996) |
| phentolamine (CHEBI:8081) is a tertiary amino compound (CHEBI:50996) |
| PI-103 (CHEBI:90524) is a tertiary amino compound (CHEBI:50996) |
| pildralazine (CHEBI:134858) is a tertiary amino compound (CHEBI:50996) |
| pimavanserin (CHEBI:133017) is a tertiary amino compound (CHEBI:50996) |
| pipamperone (CHEBI:78549) is a tertiary amino compound (CHEBI:50996) |
| pirimicarb (CHEBI:8248) is a tertiary amino compound (CHEBI:50996) |
| piromidic acid (CHEBI:32019) is a tertiary amino compound (CHEBI:50996) |
| PJ34 (CHEBI:167900) is a tertiary amino compound (CHEBI:50996) |
| plerixafor (CHEBI:125354) is a tertiary amino compound (CHEBI:50996) |
| PM00104 (CHEBI:235523) is a tertiary amino compound (CHEBI:50996) |
| pracinostat (CHEBI:95071) is a tertiary amino compound (CHEBI:50996) |
| procaine (CHEBI:8430) is a tertiary amino compound (CHEBI:50996) |
| profenamine (CHEBI:313639) is a tertiary amino compound (CHEBI:50996) |
| promazine sulfoxide (CHEBI:145225) is a tertiary amino compound (CHEBI:50996) |
| propamocarb (CHEBI:82033) is a tertiary amino compound (CHEBI:50996) |
| propiomazine (CHEBI:8491) is a tertiary amino compound (CHEBI:50996) |
| prothiocarb (CHEBI:82084) is a tertiary amino compound (CHEBI:50996) |
| prothipendyl (CHEBI:135182) is a tertiary amino compound (CHEBI:50996) |
| protonitazene (CHEBI:234363) is a tertiary amino compound (CHEBI:50996) |
| protostrychnine (CHEBI:132663) is a tertiary amino compound (CHEBI:50996) |
| pseudopelletierine (CHEBI:8607) is a tertiary amino compound (CHEBI:50996) |
| psilocin (CHEBI:8613) is a tertiary amino compound (CHEBI:50996) |
| psilocybin (CHEBI:8614) is a tertiary amino compound (CHEBI:50996) |
| PX-866 (CHEBI:65345) is a tertiary amino compound (CHEBI:50996) |
| quinacrine (CHEBI:8711) is a tertiary amino compound (CHEBI:50996) |
| rac5c (CHEBI:156041) is a tertiary amino compound (CHEBI:50996) |
| ranitidine (CHEBI:8776) is a tertiary amino compound (CHEBI:50996) |
| ranitidine-S-oxide (CHEBI:83497) is a tertiary amino compound (CHEBI:50996) |
| rauvomitine (CHEBI:142029) is a tertiary amino compound (CHEBI:50996) |
| resminostat (CHEBI:231352) is a tertiary amino compound (CHEBI:50996) |
| retuline (CHEBI:142059) is a tertiary amino compound (CHEBI:50996) |
| reversine (CHEBI:70723) is a tertiary amino compound (CHEBI:50996) |
| ricolinostat (CHEBI:95073) is a tertiary amino compound (CHEBI:50996) |
| rivastigmine (CHEBI:8874) is a tertiary amino compound (CHEBI:50996) |
| Ro 25-6981 (CHEBI:92897) is a tertiary amino compound (CHEBI:50996) |
| Ro 48-8071 (CHEBI:101064) is a tertiary amino compound (CHEBI:50996) |
| rocuronium (CHEBI:8884) is a tertiary amino compound (CHEBI:50996) |
| rohitukine (CHEBI:156498) is a tertiary amino compound (CHEBI:50996) |
| sapitinib (CHEBI:132986) is a tertiary amino compound (CHEBI:50996) |
| sarcocine (CHEBI:228288) is a tertiary amino compound (CHEBI:50996) |
| sarcodine (CHEBI:228287) is a tertiary amino compound (CHEBI:50996) |
| sarcorine (CHEBI:228274) is a tertiary amino compound (CHEBI:50996) |
| sarpagine (CHEBI:9036) is a tertiary amino compound (CHEBI:50996) |
| SCH 23390 (CHEBI:73297) is a tertiary amino compound (CHEBI:50996) |
| SCH-79797 (CHEBI:94998) is a tertiary amino compound (CHEBI:50996) |
| SCH772984 (CHEBI:167670) is a tertiary amino compound (CHEBI:50996) |
| scopolamine (CHEBI:16794) is a tertiary amino compound (CHEBI:50996) |
| secodine (CHEBI:146250) is a tertiary amino compound (CHEBI:50996) |
| selexipag (CHEBI:90844) is a tertiary amino compound (CHEBI:50996) |
| senbusine A (CHEBI:132631) is a tertiary amino compound (CHEBI:50996) |
| setiptiline (CHEBI:135076) is a tertiary amino compound (CHEBI:50996) |
| sibutramine (CHEBI:9137) is a tertiary amino compound (CHEBI:50996) |
| SKF-10,047 (CHEBI:228203) is a tertiary amino compound (CHEBI:50996) |
| Solvent yellow 56 (CHEBI:91087) is a tertiary amino compound (CHEBI:50996) |
| sonidegib (CHEBI:90863) is a tertiary amino compound (CHEBI:50996) |
| sotorasib (CHEBI:178199) is a tertiary amino compound (CHEBI:50996) |
| spiperone (CHEBI:9233) is a tertiary amino compound (CHEBI:50996) |
| spiramide (CHEBI:64207) is a tertiary amino compound (CHEBI:50996) |
| spiramycin I (CHEBI:85260) is a tertiary amino compound (CHEBI:50996) |
| spiramycin II (CHEBI:31168) is a tertiary amino compound (CHEBI:50996) |
| spiroxamine (CHEBI:9242) is a tertiary amino compound (CHEBI:50996) |
| sporidesmin A (CHEBI:9243) is a tertiary amino compound (CHEBI:50996) |
| Src Inhibitor-5 (CHEBI:78344) is a tertiary amino compound (CHEBI:50996) |
| stephanthrine (CHEBI:132896) is a tertiary amino compound (CHEBI:50996) |
| stryvomitine (CHEBI:132665) is a tertiary amino compound (CHEBI:50996) |
| SU11652 (CHEBI:132084) is a tertiary amino compound (CHEBI:50996) |
| SU4312 (CHEBI:92369) is a tertiary amino compound (CHEBI:50996) |
| tabernaemontanine (CHEBI:142075) is a tertiary amino compound (CHEBI:50996) |
| tamoxifen (CHEBI:41774) is a tertiary amino compound (CHEBI:50996) |
| tandutinib (CHEBI:90237) is a tertiary amino compound (CHEBI:50996) |
| taxine B (CHEBI:134192) is a tertiary amino compound (CHEBI:50996) |
| tenocyclidine (CHEBI:64610) is a tertiary amino compound (CHEBI:50996) |
| tenovin-6 (CHEBI:77729) is a tertiary amino compound (CHEBI:50996) |
| tertiary amine (CHEBI:32876) is a tertiary amino compound (CHEBI:50996) |
| tesevatinib (CHEBI:167674) is a tertiary amino compound (CHEBI:50996) |
| tetracaine (CHEBI:9468) is a tertiary amino compound (CHEBI:50996) |
| tetrahydrofuranylfentanyl (CHEBI:183782) is a tertiary amino compound (CHEBI:50996) |
| thenalidine (CHEBI:135187) is a tertiary amino compound (CHEBI:50996) |
| Thenyldiamine (CHEBI:186232) is a tertiary amino compound (CHEBI:50996) |
| thienylfentanyl (CHEBI:61099) is a tertiary amino compound (CHEBI:50996) |
| tiagabine (CHEBI:9586) is a tertiary amino compound (CHEBI:50996) |
| tiamulin (CHEBI:44137) is a tertiary amino compound (CHEBI:50996) |
| tilorone (CHEBI:147347) is a tertiary amino compound (CHEBI:50996) |
| tofacitinib (CHEBI:71200) is a tertiary amino compound (CHEBI:50996) |
| TOP-53 (CHEBI:134547) is a tertiary amino compound (CHEBI:50996) |
| trabectedin (CHEBI:84050) is a tertiary amino compound (CHEBI:50996) |
| triallylamine (CHEBI:192451) is a tertiary amino compound (CHEBI:50996) |
| triethanolamine (CHEBI:28621) is a tertiary amino compound (CHEBI:50996) |
| triethylenediamine (CHEBI:151129) is a tertiary amino compound (CHEBI:50996) |
| triflusulfuron (CHEBI:142847) is a tertiary amino compound (CHEBI:50996) |
| triflusulfuron-methyl (CHEBI:82047) is a tertiary amino compound (CHEBI:50996) |
| trimethobenzamide (CHEBI:27796) is a tertiary amino compound (CHEBI:50996) |
| trimipramine (CHEBI:9738) is a tertiary amino compound (CHEBI:50996) |
| TRODAT-1 (CHEBI:234467) is a tertiary amino compound (CHEBI:50996) |
| tropisetron (CHEBI:32269) is a tertiary amino compound (CHEBI:50996) |
| trovafloxacin (CHEBI:9763) is a tertiary amino compound (CHEBI:50996) |
| tubastatin A (CHEBI:94186) is a tertiary amino compound (CHEBI:50996) |
| tubulosine (CHEBI:9775) is a tertiary amino compound (CHEBI:50996) |
| ulipristal acetate (CHEBI:71025) is a tertiary amino compound (CHEBI:50996) |
| UNC0638 (CHEBI:95074) is a tertiary amino compound (CHEBI:50996) |
| UNC0642 (CHEBI:233643) is a tertiary amino compound (CHEBI:50996) |
| vaillantine (CHEBI:194501) is a tertiary amino compound (CHEBI:50996) |
| Valdiazen (CHEBI:218508) is a tertiary amino compound (CHEBI:50996) |
| vanoxerine (CHEBI:64089) is a tertiary amino compound (CHEBI:50996) |
| venlafaxine (CHEBI:9943) is a tertiary amino compound (CHEBI:50996) |
| veracevine (CHEBI:9947) is a tertiary amino compound (CHEBI:50996) |
| vincaleukoblastine (CHEBI:27375) is a tertiary amino compound (CHEBI:50996) |
| vincristine (CHEBI:28445) is a tertiary amino compound (CHEBI:50996) |
| vindesine (CHEBI:36373) is a tertiary amino compound (CHEBI:50996) |
| vindoline (CHEBI:16380) is a tertiary amino compound (CHEBI:50996) |
| vindolinine (CHEBI:141964) is a tertiary amino compound (CHEBI:50996) |
| voachalotine (CHEBI:141967) is a tertiary amino compound (CHEBI:50996) |
| volasertib (CHEBI:231358) is a tertiary amino compound (CHEBI:50996) |
| VR nerve agent (CHEBI:140422) is a tertiary amino compound (CHEBI:50996) |
| VX nerve agent (CHEBI:136185) is a tertiary amino compound (CHEBI:50996) |
| WNH (CHEBI:228402) is a tertiary amino compound (CHEBI:50996) |
| xaliproden (CHEBI:48520) is a tertiary amino compound (CHEBI:50996) |
| xestospongin C (CHEBI:131784) is a tertiary amino compound (CHEBI:50996) |
| XMD-17-51 (CHEBI:234455) is a tertiary amino compound (CHEBI:50996) |
| XMU-MP-1 (CHEBI:231615) is a tertiary amino compound (CHEBI:50996) |
| yunaconitine (CHEBI:132640) is a tertiary amino compound (CHEBI:50996) |
| ZM447439 (CHEBI:91376) is a tertiary amino compound (CHEBI:50996) |
| zotepine (CHEBI:32316) is a tertiary amino compound (CHEBI:50996) |
| α-methylfentanyl (CHEBI:234468) is a tertiary amino compound (CHEBI:50996) |
| α-putrescinylthymine (CHEBI:132931) is a tertiary amino compound (CHEBI:50996) |
| β-erythroidine (CHEBI:27795) is a tertiary amino compound (CHEBI:50996) |
| β-oxymorphamine (CHEBI:235467) is a tertiary amino compound (CHEBI:50996) |
| tertiary ammonium ion (CHEBI:137982) is conjugate acid of tertiary amino compound (CHEBI:50996) |
